{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T18:27:27Z","timestamp":1786991247107,"version":"build-2736575974"},"reference-count":57,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2013,4,1]],"date-time":"2013-04-01T00:00:00Z","timestamp":1364774400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,4,1]],"date-time":"2013-04-01T00:00:00Z","timestamp":1364774400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Affective Disorders"],"published-print":{"date-parts":[[2013,4]]},"DOI":"10.1016\/j.jad.2012.11.001","type":"journal-article","created":{"date-parts":[[2012,12,4]],"date-time":"2012-12-04T11:31:31Z","timestamp":1354620691000},"page":"310-318","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"title":["Olanzapine plus fluoxetine for bipolar disorder: A systematic review and meta-analysis"],"prefix":"10.1016","volume":"146","author":[{"given":"Marcus T.","family":"Silva","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivan R.","family":"Zimmermann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tais F.","family":"Galvao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mauricio G.","family":"Pereira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.jad.2012.11.001_bib1","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.jad.2005.02.018","article-title":"Comparison of fluoxetine, olanzapine, and combined fluoxetine plus olanzapine initial therapy of bipolar type I and type II major depression\u2014lack of manic induction","volume":"87","author":"Amsterdam","year":"2005","journal-title":"Journal of Affective Disorders"},{"issue":"4","key":"10.1016\/j.jad.2012.11.001_bib2","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.jclinepi.2010.07.015","article-title":"GRADE guidelines: 3. Rating the quality of evidence","volume":"64","author":"Balshem","year":"2011","journal-title":"Journal of Clinical Epidemiology"},{"issue":"10","key":"10.1016\/j.jad.2012.11.001_bib3","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.4088\/JCP.08m04772gre","article-title":"Olanzapine\/fluoxetine combination for the treatment of mixed depression in bipolar I disorder: a post hoc analysis","volume":"70","author":"Benazzi","year":"2009","journal-title":"Journal of Clinical Psychiatry"},{"issue":"6","key":"10.1016\/j.jad.2012.11.001_bib4","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1017\/S1461145708009735","article-title":"Olanzapine\/fluoxetine combination vs. lamotrigine in the 6-month treatment of bipolar I depression","volume":"12","author":"Brown","year":"2009","journal-title":"International Journal of Neuropsychopharmacology"},{"issue":"7","key":"10.1016\/j.jad.2012.11.001_bib5","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.4088\/JCP.v67n0703","article-title":"A 7-week, randomized, double-blind trial of olanzapine\/fluoxetine combination versus lamotrigine in the treatment of bipolar I depression","volume":"67","author":"Brown","year":"2006","journal-title":"Journal of Clinical Psychiatry"},{"issue":"22","key":"10.1016\/j.jad.2012.11.001_bib6","doi-asserted-by":"crossref","first-page":"3127","DOI":"10.1002\/1097-0258(20001130)19:22<3127::AID-SIM784>3.0.CO;2-M","article-title":"A simple method for converting an odds ratio to effect size for use in meta-analysis","volume":"19","author":"Chinn","year":"2000","journal-title":"Statistics in Medicine"},{"issue":"17","key":"10.1016\/j.jad.2012.11.001_bib7","doi-asserted-by":"crossref","first-page":"2751","DOI":"10.1517\/14656566.2011.632368","article-title":"Olanzapine-fluoxetine combination for the treatment of bipolar depression","volume":"12","author":"Citrome","year":"2011","journal-title":"Expert Opinion on Pharmacotherapy"},{"key":"10.1016\/j.jad.2012.11.001_bib8","first-page":"4","article-title":"The clinical management of bipolar disorder: a review of evidence-based guidelines","volume":"13","author":"Connolly","year":"2011","journal-title":"The Primary Care Companion for CNS Disorders"},{"issue":"5","key":"10.1016\/j.jad.2012.11.001_bib9","doi-asserted-by":"crossref","first-page":"798","DOI":"10.4088\/JCP.v67n0514","article-title":"A 24-week open-label extension study of olanzapine\u2013fluoxetine combination and olanzapine monotherapy in the treatment of bipolar depression","volume":"67","author":"Corya","year":"2006","journal-title":"Journal of Clinical Psychiatry"},{"issue":"5","key":"10.1016\/j.jad.2012.11.001_bib10","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1177\/0269881111408461","article-title":"Second generation antipsychotics in the treatment of bipolar depression: a systematic review and meta-analysis","volume":"26","author":"De Fruyt","year":"2012","journal-title":"Journal of Psychopharmacology"},{"issue":"8","key":"10.1016\/j.jad.2012.11.001_bib11","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.2165\/00003495-200868080-00008","article-title":"Olanzapine\/fluoxetine: a review of its use in the treatment of acute bipolar depression","volume":"68","author":"Deeks","year":"2008","journal-title":"Drugs"},{"issue":"6","key":"10.1016\/j.jad.2012.11.001_bib12","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1038\/sj.npp.1300950","article-title":"Neurochemical effects of olanzapine in first-hospitalization manic adolescents: a proton magnetic resonance spectroscopy study","volume":"31","author":"DelBello","year":"2006","journal-title":"Neuropsychopharmacology"},{"issue":"2","key":"10.1016\/j.jad.2012.11.001_bib13","doi-asserted-by":"crossref","first-page":"25","DOI":"10.3810\/pgm.2005.02.1585","article-title":"Latest therapies for bipolar disorder. Looking beyond lithium","volume":"117","author":"Goldberg","year":"2005","journal-title":"Postgraduate Medical"},{"issue":"4","key":"10.1016\/j.jad.2012.11.001_bib14","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1177\/0269881109102919","article-title":"Evidence-based guidelines for treating bipolar disorder: revised second edition-recommendations from the British association for psychopharmacology","volume":"23","author":"Goodwin","year":"2009","journal-title":"Journal of Psychopharmacology"},{"issue":"4","key":"10.1016\/j.jad.2012.11.001_bib15","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1177\/0269881109102919","article-title":"Evidence-based guidelines for treating bipolar disorder: revised second edition\u2014recommendations from the British Association for Psychopharmacology","volume":"23","author":"Goodwin","year":"2009","journal-title":"Journal of Psychopharmacology"},{"issue":"2","key":"10.1016\/j.jad.2012.11.001_bib16","doi-asserted-by":"crossref","first-page":"81","DOI":"10.3109\/15622970903555881","article-title":"The World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Biological Treatment of Bipolar Disorders: Update 2010 on the treatment of acute bipolar depression\u2019","volume":"11","author":"Grunze","year":"2010","journal-title":"World Journal of Biological Psychiatry"},{"issue":"9","key":"10.1016\/j.jad.2012.11.001_bib17","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1017\/S1092852900013912","article-title":"Switching, induction of rapid cycling, and increased suicidality with antidepressants in bipolar patients: fact or overinterpretation?","volume":"13","author":"Grunze","year":"2008","journal-title":"CNS Spectrums"},{"issue":"20","key":"10.1016\/j.jad.2012.11.001_bib18","doi-asserted-by":"crossref","first-page":"3443","DOI":"10.1002\/sim.2380","article-title":"A modified test for small-study effects in meta-analyses of controlled trials with binary endpoints","volume":"25","author":"Harbord","year":"2006","journal-title":"Statistics in Medicine"},{"key":"10.1016\/j.jad.2012.11.001_bib19","unstructured":"Higgins, J.Green, S. (2011) Cochrane Handbook for Systematic Reviews of Interventions, [online], available: \u3008www.cochrane-handbook.org\u3009 (accessed 19 Sep 2012)."},{"issue":"1-2","key":"10.1016\/j.jad.2012.11.001_bib20","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.psychres.2010.10.020","article-title":"Association of DRD2 and ANKK1 polymorphisms with prolactin increase in olanzapine-treated women","volume":"187","author":"Houston","year":"2011","journal-title":"Psychiatry Research"},{"key":"10.1016\/j.jad.2012.11.001_bib21","unstructured":"Houston, J.P., Degenhardt, E.L., Ahl, J., Easom, H.M., Kaiser, C. and Kinon, B.J. (2004) Suicidal Ideation Changes in Depressed Bipolar I Patients with Olanzapine\u2013fluoxetine Combination, American Psychiatric Association, 157th Annual Meeting."},{"issue":"6","key":"10.1016\/j.jad.2012.11.001_bib22","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1007\/s11920-003-0077-2","article-title":"Depressive episodes and symptoms dominate the longitudinal course of bipolar disorder","volume":"5","author":"Judd","year":"2003","journal-title":"Current Psychiatry Reports"},{"issue":"2","key":"10.1016\/j.jad.2012.11.001_bib23","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1017\/S1461145703003341","article-title":"Long-term symptomatic status of bipolar I vs. bipolar II disorders","volume":"6","author":"Judd","year":"2003","journal-title":"International Journal of Neuropsychopharmacology"},{"issue":"2","key":"10.1016\/j.jad.2012.11.001_bib24","article-title":"Is olanzapine plus fluoxetine more effective than olanzapine alone for bipolar I depression?","volume":"12","author":"Karls","year":"2009","journal-title":"Evidence-Based Practice"},{"issue":"5","key":"10.1016\/j.jad.2012.11.001_bib25","doi-asserted-by":"crossref","first-page":"611","DOI":"10.4088\/JCP.v66n0511","article-title":"Analyses of treatment-emergent mania with olanzapine\/fluoxetine combination in the treatment of bipolar depression","volume":"66","author":"Keck","year":"2005","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1016\/j.jad.2012.11.001_bib26","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1111\/j.1600-0447.2004.00410.x","article-title":"New medication treatment options for bipolar disorders","volume":"422","author":"Ketter","year":"2004","journal-title":"ACTA Psychiatrica Scandinavica"},{"issue":"5","key":"10.1016\/j.jad.2012.11.001_bib27","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1111\/j.1399-5618.2007.00467.x","article-title":"Three times more days depressed than manic or hypomanic in both bipolar I and bipolar II disorder","volume":"9","author":"Kupka","year":"2007","journal-title":"Bipolar Disorder"},{"issue":"5","key":"10.1016\/j.jad.2012.11.001_bib28","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1111\/j.1600-0447.2008.01237.x","article-title":"Are antidepressants safe in the treatment of bipolar depression? A critical evaluation of their potential risk to induce switch into mania or cycle acceleration","volume":"118","author":"Licht","year":"2008","journal-title":"ACTA Psychiatrica Scandinavica"},{"key":"10.1016\/j.jad.2012.11.001_bib29","unstructured":"Lilly (2004) Summary ID#3077. Clinical Study Summary:Study F1D-MC-HGGY. Placebo-Controlled Olanzapine Monotherapy in the Treatment of Bipolar I Depression\u2019, available: \u3008http:\/\/www.lillytrials.com\/results\/Symbyax.pdf\u3009 [accessed 19 Sep 2012]."},{"key":"10.1016\/j.jad.2012.11.001_bib30","unstructured":"Lilly (2006) Summary ID# 7980. Clinical Study Summary: Study H6P-US-HDAQ. Olanzapine\/fluoxetine Combination versus Comparator in the Treatment of Bipolar I Depression, available: \u3008http:\/\/www.lillytrials.com\/results\/Symbyax.pdf\u3009 [accessed 19 Sep 2012]."},{"key":"10.1016\/j.jad.2012.11.001_bib31","unstructured":"Lilly (2007) Summary ID# 9370. Clinical Study Summary: Study F1D-SU-HGMA.Study F1D-SU-HGMA: Bipolar depression assessment study on treatment response (BiDAS-TR), [online], available: \u3008http:\/\/www.lillytrials.com\/results\/Symbyax.pdf\u3009 (accessed 19 Sep 2012)."},{"issue":"4","key":"10.1016\/j.jad.2012.11.001_bib32","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/0166-3542(87)90074-X","article-title":"Herpes simplex virus as an inducer of interferon in human monocyte cultures","volume":"8","author":"Linnavuori","year":"1987","journal-title":"Antiviral Research"},{"issue":"4","key":"10.1016\/j.jad.2012.11.001_bib33","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.eurpsy.2010.12.008","article-title":"A randomised controlled trial of carer-focussed multi-family group psychoeducation in bipolar disorder","volume":"27","author":"Madigan","year":"2012","journal-title":"European Psychiatry"},{"issue":"1","key":"10.1016\/j.jad.2012.11.001_bib34","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1097\/YCO.0b013e32834de3de","article-title":"The \u2018true\u2019 prevalence of bipolar II disorder","volume":"25","author":"Merikangas","year":"2012","journal-title":"Current Opinion in Psychiatry"},{"issue":"2","key":"10.1016\/j.jad.2012.11.001_bib35","first-page":"8","article-title":"Questions and answers. What is Symbyax, the new drug being marketed for the treatment of bipolar depression","volume":"21","author":"Miller","year":"2004","journal-title":"Harvard Mental Health Letter"},{"key":"10.1016\/j.jad.2012.11.001_bib36","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1186\/1471-244X-11-114","article-title":"Pragmatic randomised controlled trial of group psychoeducation versus group support in the maintenance of bipolar disorder","volume":"11","author":"Morriss","year":"2011","journal-title":"BMC Psychiatry"},{"issue":"1-3","key":"10.1016\/j.jad.2012.11.001_bib37","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.jad.2010.05.018","article-title":"New treatment guidelines for acute bipolar depression: a systematic review","volume":"129","author":"Nivoli","year":"2011","journal-title":"Journal of Affective Disorders"},{"issue":"6","key":"10.1016\/j.jad.2012.11.001_bib38","doi-asserted-by":"crossref","first-page":"803","DOI":"10.4088\/JCP.11m07343","article-title":"A randomized controlled trial of psychoeducation or cognitive-behavioral therapy in bipolar disorder: a Canadian Network for Mood and Anxiety treatments (CANMAT) study [CME]","volume":"73","author":"Parikh","year":"2012","journal-title":"Journal of Clinical Psychiatry"},{"issue":"6","key":"10.1016\/j.jad.2012.11.001_bib39","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1001\/jama.295.6.676","article-title":"Comparison of two methods to detect publication bias in meta-analysis","volume":"295","author":"Peters","year":"2006","journal-title":"Journal of the American Medical Association"},{"key":"10.1016\/j.jad.2012.11.001_bib40","series-title":"Maintenance Treatment","article-title":"Bipolar Disorder in Adults","author":"Post","year":"2012"},{"key":"10.1016\/j.jad.2012.11.001_bib41","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1192\/bjp.bp.105.013045","article-title":"Mood switch in bipolar depression: comparison of adjunctive venlafaxine, bupropion and sertraline","volume":"189","author":"Post","year":"2006","journal-title":"British Journal of Psychiatry"},{"issue":"4","key":"10.1016\/j.jad.2012.11.001_bib42","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1111\/j.1399-5618.2008.00588.x","article-title":"Impact of caregiver group psychoeducation on the course and outcome of bipolar patients in remission: a randomized controlled trial","volume":"10","author":"Reinares","year":"2008","journal-title":"Bipolar Disorder"},{"key":"10.1016\/j.jad.2012.11.001_bib43","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1034\/j.1399-5618.2000.20306.x","article-title":"The treatment of bipolar depression","volume":"2","author":"Sachs","year":"2000","journal-title":"Bipolar Disorder"},{"key":"10.1016\/j.jad.2012.11.001_bib44","unstructured":"Sch\u00fcnemann, H., Bro\u017cek, J. and Oxman, A. (2009) GRADE Handbook for Grading Quality of Evidence and Strength of Recommendation. Version 3.2, available: \u3008http:\/\/ims.cochrane.org\/gradepro\u3009 (accessed 19 Sep 2012)."},{"issue":"1","key":"10.1016\/j.jad.2012.11.001_bib45","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0149-2918(04)90013-6","article-title":"Effects of olanzapine alone and olanzapine\/fluoxetine combination on health-related quality of life in patients with bipolar depression: secondary analyses of a double-blind, placebo-controlled, randomized clinical trial","volume":"26","author":"Shi","year":"2004","journal-title":"Clinical Therapeutics"},{"issue":"39","key":"10.1016\/j.jad.2012.11.001_bib46","doi-asserted-by":"crossref","DOI":"10.3310\/hta11390","article-title":"A systematic review and economic model of the clinical effectiveness and cost-effectiveness of interventions for preventing relapse in people with bipolar disorder","volume":"11","author":"Soares-Weiser","year":"2007","journal-title":"Health Technology Assessment"},{"issue":"3","key":"10.1016\/j.jad.2012.11.001_bib47","doi-asserted-by":"crossref","first-page":"356","DOI":"10.4088\/JCP.09r05192gre","article-title":"Pharmacotherapy for the treatment of acute bipolar II depression: current evidence","volume":"72","author":"Swartz","year":"2011","journal-title":"Journal of Clinical Psychiatry"},{"issue":"4","key":"10.1016\/j.jad.2012.11.001_bib48","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1097\/JCP.0b013e3181ad223f","article-title":"Effectiveness and safety of the combination of fluoxetine and olanzapine in outpatients with bipolar depression: an open-label, randomized, flexible-dose study in Puerto Rico","volume":"29","author":"Tamayo","year":"2009","journal-title":"Journal of Clinical Psychopharmacology"},{"issue":"2","key":"10.1016\/j.jad.2012.11.001_bib49","doi-asserted-by":"crossref","first-page":"224","DOI":"10.4088\/JCP.v68n0207","article-title":"A randomized, double-blind comparison of olanzapine\/fluoxetine combination, olanzapine, and fluoxetine in treatment-resistant major depressive disorder","volume":"68","author":"Thase","year":"2007","journal-title":"Journal of Clinical Psychiatry"},{"issue":"1-3","key":"10.1016\/j.jad.2012.11.001_bib50","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.jad.2007.03.014","article-title":"Effect of comorbid anxiety on treatment response in bipolar depression","volume":"104","author":"Tohen","year":"2007","journal-title":"Journal of Affective Disorders"},{"issue":"11","key":"10.1016\/j.jad.2012.11.001_bib51","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1001\/archpsyc.60.11.1079","article-title":"Efficacy of olanzapine and olanzapine\u2013fluoxetine combination in the treatment of bipolar I depression","volume":"60","author":"Tohen","year":"2003","journal-title":"Archives of General Psychiatry"},{"issue":"3","key":"10.1016\/j.jad.2012.11.001_bib52","doi-asserted-by":"crossref","first-page":"387","DOI":"10.4088\/JCP.08m04064","article-title":"An integrated analysis of olanzapine\/fluoxetine combination in clinical trials of treatment-resistant depression","volume":"70","author":"Trivedi","year":"2009","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1016\/j.jad.2012.11.001_bib53","article-title":"A randomized, controlled, pilot study of dialectical behavior therapy skills in a psychoeducational group for individuals with bipolar disorder","author":"Van Dijk","year":"2012","journal-title":"Journal of Affective Disorders"},{"issue":"1-3","key":"10.1016\/j.jad.2012.11.001_bib54","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.jad.2009.02.028","article-title":"Predominant previous polarity as an outcome predictor in a controlled treatment trial for depression in bipolar I disorder patients","volume":"119","author":"Vieta","year":"2009","journal-title":"Journal of Affective Disorders"},{"issue":"5","key":"10.1016\/j.jad.2012.11.001_bib55","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1097\/JCP.0b013e3181f15849","article-title":"Treatment options for bipolar depression: a systematic review of randomized, controlled trials","volume":"30","author":"Vieta","year":"2010","journal-title":"Journal of Clinical Psychopharmacology"},{"issue":"2-3","key":"10.1016\/j.jad.2012.11.001_bib56","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.jad.2006.02.011","article-title":"Clinical relevance of depressive symptom improvement in bipolar I depressed patients","volume":"92","author":"Williamson","year":"2006","journal-title":"Journal of Affective Disorders"},{"issue":"3","key":"10.1016\/j.jad.2012.11.001_bib57","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1111\/j.1399-5618.2009.00672.x","article-title":"Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2009","volume":"11","author":"Yatham","year":"2009","journal-title":"Bipolar Disorder"}],"container-title":["Journal of Affective Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032712007355?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032712007355?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T01:11:25Z","timestamp":1759021885000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165032712007355"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,4]]},"references-count":57,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,4]]}},"alternative-id":["S0165032712007355"],"URL":"https:\/\/doi.org\/10.1016\/j.jad.2012.11.001","relation":{},"ISSN":["0165-0327"],"issn-type":[{"value":"0165-0327","type":"print"}],"subject":[],"published":{"date-parts":[[2013,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Olanzapine plus fluoxetine for bipolar disorder: A systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Journal of Affective Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jad.2012.11.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}